TY  - JOUR
AU  - Ariza, Adriana
AU  - Jaruthamsophon, Kanoot
AU  - Meng, Xiaoli
AU  - Labella, Marina
AU  - Adair, Kareena
AU  - Tailor, Arun
AU  - Sukasem, Chonlaphat
AU  - Whitaker, Paul
AU  - Peckham, Daniel
AU  - Pirmohamed, Munir
AU  - Torres, María José
AU  - Naisbitt, Dean John
PY  - 2022
DO  - 10.1021/acs.chemrestox.2c00231
UR  - http://hdl.handle.net/10668/22586
T2  - Chemical research in toxicology
AB  - β-Lactamase inhibitors such as clavulanic acid and tazobactam were developed to overcome β-lactam antibiotic resistance. Hypersensitivity reactions to these drugs have not been studied in detail, and the antigenic determinants that activate T-cells...
LA  - en
KW  - Humans
KW  - Clavulanic Acid
KW  - Tazobactam
KW  - Epitopes
KW  - T-Lymphocytes
KW  - beta-Lactamase Inhibitors
KW  - Anti-Bacterial Agents
KW  - Aldehydes
TI  - Shared Clavulanate and Tazobactam Antigenic Determinants Activate T-Cells from Hypersensitive Patients.
TY  - research article
VL  - 35
ER  -